Home FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug
 

Keywords :   


FDA Removes Clinical Hold on Study of Pancreatic Cancer Drug

2014-06-08 05:12:05| Biotech - Topix.net

The FDA has removed its clinical hold on patient enrollment and dosing of PEGPH20 in an ongoing phase II trial evaluating the investigational compound in patients with pancreatic cancer, permitting the study to resume under a revised protocol.

Tags: study hold drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11 BUG ! TOO !
23.11BTS 10 FESTA ARMY JUNGKOOK
23.11 SAO 2015
23.1178580g
23.112
23.1170
23.11 BOX
23.11
More »